Full Schedule

08:00 - 16:00 CET

National/Regional Society Sessions

16:00 - 17:30 CET

Opening Ceremonies

17:30 - 19:00 CET

Networking Event

07:30 - 09:00 CET

Surgery Day - Session 1 - Endourology & Stones

07:30 - 08:00 CET

RIRS

08:00 - 08:20 CET

Lower Pole Stone

08:00 - 08:20 CET

Mini PCNL

08:20 - 08:40 CET

Suction in Endourology

08:40 - 09:00 CET

Prone PCNL

08:40 - 09:00 CET

Supine PCNL

08:00 - 09:00 CET

Moderated Oral/Video ePoster Sessions

09:15 - 11:00 CET

Plenary 01

Honorary Chair: – Macquarie University Hospital

Honorary Chair: – Baylor College of Medicine

Honorary Chair: – The Chinese University of Hong Kong

09:15 - 09:18 CET

Welcome and Introductions

09:18 - 09:33 CET

SIU-Mostafa M. Elhilali Award Lecture

09:33 - 09:48 CET

Society Lecture

09:48 - 10:03 CET

Society Lecture

10:03 - 10:18 CET

Gambia Mission - The Last 20 Years

10:18 - 10:33 CET

The Emotional Toll of Surgical Complications: Strategies to Take Care of Ourselves

Speaker: – University of California San Diego

10:33 CET

Debate – Treating Muscle Invasive Bladder Cancer - Platinum-Based Chemotherapy On Life Support – Emergence Of ADCs And Immune Checkpoint Inhibition

10:33 - 10:40 CET

Pro (Chemo Is on Life Support)

10:40 - 10:47 CET

Con (Chemotherapy Still Relevant)

Speaker: – Hassan II University Hospital

10:53 - 10:58 CET

SIUJ Awards

10:58 - 11:00 CET

Closing Remarks

10:45 - 11:15 CET

Networking Break

11:00 - 17:30 CET

Workshop: Prostate MRI & Transperineal Prostate Biopsy Course

Co-Chair: – University of Cambridge

11:15 - 12:40 CET

Surgery Day - Session 2 - LUTS/BPO

11:15 - 11:30 CET

Simple Prostatectomy for BPH

11:30 - 11:50 CET

BipolEP

11:30 - 11:50 CET

HoLEP

11:55 - 12:10 CET

Paclitaxel-Coated Balloon for Urethral Stricture

12:10 - 12:25 CET

Prostatic Urethral Lift System for BPH

12:25 - 12:40 CET

Aqubalation for BPH

11:15 - 12:45 CET

Controversies in Urology: Localized Kidney Cancer - Diagnostic and Treatment Dilemmas

Co-Chair: – Hospital Alemán of Buenos Aires

Kidney Cancer

11:15 CET

Module 1 – Imaging

Kidney Cancer

11:15 - 11:25 CET

Imaging in localized renal cancer where are we in 2026 ?

Speaker: – Mediclinic

Kidney Cancer

11:25 - 11:35 CET

Surgical navigation, VR and AR

Kidney Cancer

11:35 CET

Module 2 – Crossfire – Current Role of biopsy

Kidney Cancer

11:35 - 11:55 CET

Case based crossfire / 3 cases regarding the role of kidney biopsy

Speaker:

Kidney Cancer

11:55 CET

Module 3 – Case presentation – 3 cm small renal mass on healthy young male

Kidney Cancer

11:55 - 12:05 CET

Active surveillance vs Partial nephrectomy

Speaker: – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel

Kidney Cancer

12:05 CET

Case presentation – 4 cm renal mass, multiple comorbidities, poor surgical candidate

Kidney Cancer

12:05 - 12:15 CET

SBRT vs ablative therapies vs AS

Kidney Cancer

12:15 CET

Module 4 – Surgical Arena – Commented videos

Kidney Cancer

12:15 - 12:25 CET

Minimally invasive PN in complex cases (lap and robotic)

Kidney Cancer

12:25 - 12:35 CET

Moving Forward by going Retro and single port

Speaker: – Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA

Kidney Cancer

12:35 CET

Module 5 – Training

Kidney Cancer

12:35 - 12:45 CET

Surgical training for minimally invasive partial nephrectomy

Speaker: – Hospital Alemán of Buenos Aires

Kidney Cancer

11:15 - 12:45 CET

Instructional Course: High-Quality TURBT - Practical Strategies to Improve Outcomes

Co-Chair: – Clínica Alemana Universidad del Desarrollo

Co-Chair: – University of Texas MD Anderson Cancer Center

Bladder Cancer

11:15 - 11:20 CET

Welcome and Introduction

Speaker: – Clínica Alemana Universidad del Desarrollo

Speaker: – University of Texas MD Anderson Cancer Center

Bladder Cancer

11:20 - 11:30 CET

Why TURBT Quality Still Matters in 2026 – Impact on NMIBC Outcomes

Speaker: – University of Texas MD Anderson Cancer Center

Bladder Cancer

11:30 CET

EXPERT TALK I – SURGICAL STANDARDS - WHAT DEFINES A HIGH-QUALITY TURBT?

Bladder Cancer

11:30 - 11:35 CET

Pre-Operative Assessment and Planning

Speaker: – Tata Memorial Hospital, Homi Bhabha National Institute

Bladder Cancer

11:35 - 11:40 CET

En bloc vs Conventional TURBT: Evidence-Based Indications

Speaker: – The Chinese University of Hong Kong

Bladder Cancer

11:40 - 11:45 CET

Mandatory Detrusor Muscle Sampling In Every Patient?

Speaker: – Clínica Alemana Universidad del Desarrollo

Bladder Cancer

11:45 - 11:50 CET

Managing Large and Multifocal Tumors

Speaker: – University of Texas MD Anderson Cancer Center

Bladder Cancer

11:50 CET

INTERACTIVE SURGICAL VIDEO PEARLS - TURBT IN PRACTICE: DOING IT RIGHT

Bladder Cancer

11:50 - 11:58 CET

Muscle Identification and Specimen Integrity

Speaker: – The Chinese University of Hong Kong

Bladder Cancer

11:58 - 12:06 CET

Common Technical Pitfalls – Obturator Reflex, Bladder Wall Perforation, Resection Of Ureteral Orifice And Massive Intraoperative Bleeding

Speaker: – Universidad Veracruzana

Bladder Cancer

12:06 - 12:14 CET

Reducing Thermal Artifact and Incomplete Resection

Speaker: – Tata Memorial Hospital, Homi Bhabha National Institute

Bladder Cancer

12:15 CET

EXPERT TALK II – BEYOND THE RESECTION - TURBT QUALITY AND CLINICAL DECISION-MAKING

Bladder Cancer

12:15 - 12:20 CET

When and Why to Perform Re-TURBT

Speaker: – Universidad Veracruzana

Bladder Cancer

12:20 - 12:25 CET

Immediate Intravesical Therapy: Patient Selection

Speaker: – Clínica Alemana Universidad del Desarrollo

Bladder Cancer

12:25 - 12:45 CET

DISCUSSION AND TAKE-HOME MESSAGES: What To Change Tomorrow in Your OR – Key Messages For Daily Practice

Moderator: – Clínica Alemana Universidad del Desarrollo

Moderator: – University of Texas MD Anderson Cancer Center

Panelist: – Tata Memorial Hospital, Homi Bhabha National Institute

Panelist: – The Chinese University of Hong Kong

Panelist: – Universidad Veracruzana

Bladder Cancer

11:15 - 12:45 CET

Instructional Course: Prostate Cancer Management in the Era of Artificial Intelligence

Co-Chair: – Sapienza University of Rome

Prostate Cancer

11:15 - 11:30 CET

Artificial Intelligence - Where do we Stand?

Speaker: – University of Palermo

Prostate Cancer

11:30 - 11:45 CET

Natural Language Models in Prostate Cancer

Speaker: – Moffitt Cancer Center

Prostate Cancer

11:45 - 12:00 CET

Artificial Intelligence and Imaging

Prostate Cancer

12:00 - 12:15 CET

Artificial Intelligence in Prostate Biopsies and Histopathology

Speaker: – Rutgers Health, Newark, New Jersey, USA

Prostate Cancer

12:15 - 12:30 CET

Augmented Reality in Prostate Cancer

Speaker: – Sapienza University of Rome

Prostate Cancer

12:30 - 12:45 CET

Discussion and Prostate Cancer Cases With NLP

Moderator:

Prostate Cancer

11:15 - 12:45 CET

Master Class: BPH Surgery & MIST: Controversies, Complications, and Salvage Pathways

Co-Chair: – University of Toronto

Co-Chair: – Niguarda Hospital

BPH/LUTS

11:15 - 11:27 CET

Enucleation Across Settings: Technique Options, Learning Curve, and Standardization

Speaker: – Sapienza University of Rome

BPH/LUTS

11:27 CET

Point–Counterpoint Debate (14 min): “MIST should be First-Line Interventional Therapy for prostates ~30–80 mL

BPH/LUTS

11:27 - 11:34 CET

Pro

BPH/LUTS

11:34 - 11:41 CET

Con

Speaker:

BPH/LUTS

11:41 - 11:53 CET

MIST and “newer Tech” Integration: Indications, Contraindications, and Counseling

Speaker: – Niguarda Hospital

BPH/LUTS

11:53 - 12:15 CET

Salvage after failure: persistent LUTS after MIST/TURP/HoLEP and the functional workup

BPH/LUTS

12:15 - 12:45 CET

Discussion / Q&A

Moderator: – University of Toronto

Moderator: – Niguarda Hospital

BPH/LUTS

11:15 - 12:45 CET

Resident Mentoring

Chair: – Mass General Brigham | Harvard Medical School

11:15 - 12:45 CET

SIU Tips & Tricks in Urologic Publishing: SIUJ

12:45 - 14:00 CET

Networking Break

14:00 - 15:30 CET

Controversies in Urology: The Changing Paradigm in Treating Localized Prostate Cancer

Co-Chair: – University of Michigan

Prostate Cancer

14:00 - 14:13 CET

Active Surveillance: Can Imaging and Biomarkers Replace Repeated Biopsies?

Speaker: – Mediclinic

Prostate Cancer

14:13 - 14:26 CET

Novel Ablations for Prostate Cancer – Microwave, Steam, Waterjet, and TULSA

Prostate Cancer

14:26 CET

Debate - Favorable Intermediate Risk Disease:

Prostate Cancer

14:26 - 14:39 CET

AS Is the Standard of Care - Stop Overtreating!

Prostate Cancer

14:39 - 14:52 CET

Focal Therapy Please - Delay No More!

Speaker: – McGill University

Prostate Cancer

14:52 - 15:05 CET

Continence-preserving Techniques in Radical Prostatectomy in 2026 - Did We Improve Stress Incontinence in the Long Run?

Speaker:

Prostate Cancer

15:05 - 15:18 CET

The Revival of Neoadjuvant Therapy for Radical Prostatectomy

Speaker:

Prostate Cancer

15:18 - 15:30 CET

Role of Rectal Spacing in Localized Prostate Cancer - From Primary EBRT to Salvage Prostatectomy

Prostate Cancer

14:00 - 15:30 CET

Hot Topic: Bladder Cancer: New Agents in the Setting of Unequal Access Across the World

Co-Chair: – Clínica Alemana Universidad del Desarrollo

Co-Chair: – University of Texas Medical Branch, USA, Texas

Bladder Cancer

14:00 - 14:15 CET

Rapidly Evolving Treatment Landscape in BC. What Are the Reasonable Thresholds for a Drug to Become the New Standard?

Speaker: – University of Chicago

Bladder Cancer

14:15 - 14:30 CET

Clinical and Logistical Challenges of Perioperative Systemic Therapy for MIBC in Emerging Regions

Speaker: – Hassan II University Hospital

Bladder Cancer

14:30 CET

Panel 1. Global Practice Variation in NMIBC

Bladder Cancer

14:30 - 14:38 CET

What Is the Real Need for New Agents If BCG Treatment Is Adequate?

Speaker: – Clínica Alemana Universidad del Desarrollo

Bladder Cancer

14:38 - 14:46 CET

Generic Agents as More Accessible Alternatives in Emerging Regions

Speaker: – Aga Khan University

Bladder Cancer

14:46 - 14:54 CET

New Drugs for NMIBC – Will They Be Cost Efficient?

Speaker: – University of Texas Medical Branch, USA, Texas

Bladder Cancer

14:54 - 15:04 CET

Discussion

Bladder Cancer

15:04 CET

Panel 2. Radical Cystectomy – Still the way to go in BCG-unresponsive NMBIC?

Bladder Cancer

15:04 - 15:12 CET

Early Cystectomy: A Value‑Driven Approach to Managing BCG‑Unresponsive NMIBC

Speaker:

Bladder Cancer

15:12 - 15:20 CET

Early Cystectomy Optimizes Cancer Control and Quality of Life

Speaker: – University of British Columbia

Bladder Cancer

15:20 - 15:30 CET

Discussion

Bladder Cancer

14:00 - 15:30 CET

Hot Topic: Evidence‑Based Innovation & Global Standards in Endourology

Co-Chair: – "Saint John" Emergency Clinical Hospital

Co-Chair:

Co-Chair: – Menoufia University- Egypt

Endourology & Stones

14:00 - 14:11 CET

Intra Vesical Pressure - What We Are Learning?

Speaker: – Menoufia University

Endourology & Stones

14:11 - 14:22 CET

How Long Is Too Long? Procedure Duration in RIRS and Its Impact on Ureteral Safety

Speaker: – Hong Kong

Endourology & Stones

14:22 - 14:33 CET

Suction or No Suction in PCNL Evidence versus Experience

Speaker: – Urology Department, Hamad Medical Corporation, College of Medicine, Qatar University, Qatar

Endourology & Stones

14:33 - 14:44 CET

The Laser War 2: TFL vs. High-power ho:yag — Intrarenal Temperature Thresholds: Have We Found the Limit?

Speaker: – Botkin Moscow Multidisciplinary Clinical Medical Center

Endourology & Stones

14:44 - 14:55 CET

ECIRS in Resource Limited Settings: Strategies to Adopt

Speaker: – Universitas Indonesia Hospital

Endourology & Stones

14:55 - 15:06 CET

Challenges and Solutions for the Unstented Ureter Access

Endourology & Stones

15:06 - 15:17 CET

First-hand Evidence on Which Endourology Intervention Is Best Suited for Midpole Lithiasis

Speaker: – HMC

Endourology & Stones

15:17 - 15:30 CET

Discussion/Q&A

Endourology & Stones

14:00 - 15:30 CET

Master Class: Pediatric Hypospadia and Its Challenges

Pediatrics

14:00 - 14:10 CET

Welcome and Session Overview

Pediatrics

14:10 - 14:25 CET

From Hypospadias to DSD: From Evaluation to Early Decision-Making

Pediatrics

14:25 - 14:40 CET

How to Deal with Chordee

Pediatrics

14:40 - 14:55 CET

Hypospadia: When Performing Staging techniques?

Pediatrics

14:55 - 15:10 CET

Management , Follow-up in Primary or Redo Hypospadia in Adolescent Cases?

Pediatrics

15:10 - 15:30 CET

Q&A and Key Take-Home Message

Pediatrics

14:00 - 15:30 CET

National Society Delegates

Endourology & Stones

14:00 - 15:30 CET

SIU Tips and Tricks: Academy

14:00 - 15:50 CET

Surgery Day - Session 3 - Uro-Oncology and Focal Therapy

14:00 - 14:45 CET

Robotic Partial Nephrectomy

14:00 - 14:45 CET

Robotic Radical Prostatectomy With Telesurgery

14:45 - 15:30 CET

Retzius-Sparing Robotic Radical Prostatectomy

14:45 - 15:30 CET

Robotic Partial Nephrectomy

15:30 - 15:50 CET

Focal Therapy

15:30 - 15:50 CET

Nerve-Sparing Robotic Radical Prostatectomy

15:30 - 16:00 CET

Networking Break

16:00 - 17:00 CET

Surgery Day - Session 4 - Reconstruction

16:00 - 16:15 CET

Robotic Kidney Transplantation

16:15 - 16:30 CET

Urethroplasty - Panurethral Stricture

16:30 - 16:45 CET

Rectourethral Fistula

16:45 - 17:00 CET

Primary Hypospadias

17:20 - 17:30 CET

Panel Discussion & Q&A

Andrology/Sexual Medicine

16:00 - 17:30 CET

Controversies, Ethics & Innovation in Andrology

Co-Chair: – University of Washington

Co-Chair:

Andrology/Sexual Medicine

16:00 CET

Debate: Regenerative Therapies in Sexual Medicine

Andrology/Sexual Medicine

16:00 - 16:07 CET

Pro

Speaker: – University of Washington

Andrology/Sexual Medicine

16:07 - 16:15 CET

Con

Speaker: – Bristol Urological Institute

Andrology/Sexual Medicine

16:15 CET

Peyronie’s Disease – Case-based & Evidence-based Care

Andrology/Sexual Medicine

16:15 - 16:22 CET

Conservative Management Strategies

Speaker: – University of Texas Medical Branch

Andrology/Sexual Medicine

16:22 - 16:29 CET

Plication Surgery

Andrology/Sexual Medicine

16:29 - 16:36 CET

Plaque Incision and Grafting

Andrology/Sexual Medicine

16:36 - 16:43 CET

Penile Implant Surgery Alone

Andrology/Sexual Medicine

16:43 - 16:50 CET

Penile Implant Surgery with Adjunct Maneuvers

Andrology/Sexual Medicine

16:50 - 17:00 CET

Penile Prosthesis Trends and Statistics Worldwide

Speaker: – Tanta university, Egypt

Andrology/Sexual Medicine

17:00 - 17:10 CET

Ethics, Consent & Genital Augmentation

Andrology/Sexual Medicine

17:10 - 17:20 CET

Social Media, Misinformation & the Commercialisation of Andrology

Speaker: – Manchester University NHS Foundation Trust

Andrology/Sexual Medicine

16:00 - 17:30 CET

Instructional Course: Saving the Bladder in Muscle-invasive Bladder Cancer: Multidisciplinary Tips and Tricks

Bladder Cancer

16:00 - 17:30 CET

Master Class: Advanced Prostate Cancer - It’s Not Only About Drugs

Co-Chair: – Sefako Makgatho Health Sciences University

Co-Chair: – University of Palermo

Prostate Cancer

16:00 - 16:15 CET

Biochemical Recurrence After Radiotherapy – What Are the Options in 2026?

Prostate Cancer

16:15 - 16:30 CET

De-escalation in mHSPC: Who, how and when?

Speaker:

Prostate Cancer

16:30 - 16:45 CET

Management of Oligometastasic Prostate Cancer in the PSMA PET Era

Speaker: – Bashkir state medical university

Prostate Cancer

16:45 - 17:00 CET

Drug Interactions of Androgen Receptor Pathway Inhibitors: Pharmacological Principles and Real World Implications

Speaker:

Prostate Cancer

17:00 - 17:15 CET

The ABCs of Genomic testing for prostate cancer – what do Urologists need to know?

Speaker: – Sefako Makgatho Health Sciences University

Prostate Cancer

17:15 - 17:30 CET

Cardio-toxicities of Systematic Therapies for Prostate Cancer – How Can We Reduce the Harms?

Prostate Cancer

16:00 - 17:30 CET

Master Class: Advanced Kidney Cancer - Evidence-Based Surgical and Systemic Decision-Making

Co-Chair: – Mass General Brigham | Harvard Medical School

Co-Chair: – Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA

Kidney Cancer

16:00 - 16:10 CET

Perioperative Crossroads in Localized RCC: Adjuvant Immunotherapy - When and for Whom?

16:10 - 16:20 CET

Unexpected Tumor Rupture During Robotic Partial Nephrectomy

Speaker: – University of Verona

16:20 - 16:30 CET

Local and Regional Recurrence After Nephrectomy

Speaker: – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel

16:30 - 16:40 CET

IVC Tumor Thrombectomy in the Immunotherapy Era: A Modern Playbook For Indications, Techniques, And Robotic Approaches

Speaker:

16:40 - 16:50 CET

The Contemporary Role of Cytoreductive Nephrectomy in Metastatic RCC

Speaker: – Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA, USA

16:50 - 17:00 CET

Systemic Therapy for Advanced RCC: First-Line Selection and Sequencing - What Urologists Need to Know

17:00 - 17:10 CET

Delayed Partial Nephrectomy After Immunotherapy for Advanced Kidney Cancer: Feasibility, Patient Selection, and Early Oncologic Outcomes

17:10 - 17:30 CET

Discussion/Q&A

16:00 - 17:30 CET

Master Class: Pelvic Floor Health from Continence to Sexual Well-being

Co-Chair: – Baylor College of Medicine

Co-Chair: – Royal Melbourne Hospital

Female Pelvic Medicine

16:00 CET

Global Roundtable: Focus on the Outlet

Female Pelvic Medicine

16:00 CET

Non Mesh Alternatives for Management of Female Stress Incontinence

Female Pelvic Medicine

16:00 - 16:06 CET

Bulking Agents

Speaker:

Female Pelvic Medicine

16:06 - 16:12 CET

Native Tissue Suspension Procedures – a Thing of the Past? When to Use (pubourethral Ligament Plication, Burch Colposuspension)

Female Pelvic Medicine

16:12 - 16:18 CET

Fascial slings: which graft site and why? (autologous - rectus/fascia lata vs allograft - cadaveric fascia Lata)

Speaker: – Royal Melbourne Hospital

Female Pelvic Medicine

16:18 - 16:24 CET

Robotic Artificial Urinary Sphincter, Are They Only a Last Resort?

Female Pelvic Medicine

16:24 - 16:30 CET

Management of the Devastated Outlet in the Female Neurourological Patient

Speaker: – University of Lisbon, School of Medicine, Lisbon, Portugal

Female Pelvic Medicine

16:30 - 16:45 CET

Discussion/Q&A

Female Pelvic Medicine

16:45 CET

Global Roundtable: Female Sexual Dysfunction and Genitourinary Syndrome of Menopause - Has Our Management of Female Sexual Dysfunction Improved over the Last Decade?

Female Pelvic Medicine

16:45 - 16:53 CET

Is It All About Hormones? Improving Education, Awareness and Treatment of GSM

Female Pelvic Medicine

16:53 - 17:01 CET

So Many Pills for Male Sexual Dysfunction, What’s Available for Women?

Speaker: – Baylor College of Medicine

Female Pelvic Medicine

17:01 - 17:09 CET

Restoring and Optimizing Sexual Function After Radical Genitourinary Cancer Treatments in Women

Speaker: – Aarhus University Hospital

Female Pelvic Medicine

17:09 - 17:18 CET

Vaginal Rejuvenation – Myth or Bust?

Speaker:

Female Pelvic Medicine

17:18 - 17:30 CET

Discussion/Q&A

Female Pelvic Medicine

16:00 - 17:30 CET

SIU Tips and Tricks - uCare

Chair: – Seoul National University Bundang Hospital

08:00 - 09:00 CET

General Assembly

08:00 - 09:00 CET

Moderated Oral/Video ePoster Sessions

09:00 - 10:00 CET

Plenary 02

Honorary Chair: – Medical School, University of Cyprus

09:00 - 09:02 CET

Welcome and Introductions

09:02 - 09:17 CET

Society Lecture

09:17 - 09:31 CET

Renal Cell Carcinoma and Caval Thrombectomy – Optimizing Safety and Complete Resection

Speaker: – University Hospital Cologne

09:31 - 09:45 CET

Digital Healthcare 2026 for Robotic Surgery: Age of Generative AI

09:45 - 09:59 CET

Compelling Evidence and Breakthroughs in Robotic Aquablation Therapy

Speaker:

09:59 - 10:00 CET

Closing Remarks

10:00 - 10:30 CET

Networking Break

10:00 - 11:50 CET

8th Bench-to-bedside Uro-oncology: GU Cancers Triad Meeting - BLADDER CANCER

Moderator: – University of British Columbia

10:00 - 10:05 CET

Welcome and Introductions

Co-Chair: – University of British Columbia

Co-Chair: – McGill University

10:05 - 10:20 CET

First-Line Therapy for High-Risk NMIBC

10:20 - 10:50 CET

Case-Based Discussion: Intravesical Therapy Selection for BCG-unresponsive NMIBC

Moderator: – University of British Columbia

Panelist: – Austria

10:50 - 11:05 CET

Novel PET Imaging and Theranostics in Bladder Cancer

Speaker: – Austria

11:05 - 11:35 CET

Case-Based Discussion: Perioperative Systemic Therapy for MIBC

Moderator: – Austria

Panelist: – University of British Columbia

11:35 - 11:50 CET

Treatment Sequencing in Advanced Bladder Cancer After Enfortumab Vedotin and Pembrolizumab

10:15 - 12:15 CET

Workshop: Laparascopy for Beginners

Co-Chair: – Newcastle's Freeman Hospital

Co-Chair: – Hospital Alemán of Buenos Aires

10:30 - 12:00 CET

Emirates Urological Society (EUS) Roundtable Session

10:30 - 12:00 CET

Hot Topic: Complex Scenarios & Rescue Strategies in Endourology

Co-Chair: – North Bristol NHS Trust

Endourology & Stones

10:30 - 10:41 CET

The Difficult Proximal Ureteric Stone: My Five Management Strategies

Speaker: – Tan Tock Seng Hospital, National Healthcare Group, Singapore

Endourology & Stones

10:41 - 10:52 CET

Flexible Ureteroscopy in Infectious Stones: Is It Possible??

Speaker: – Menoufia University- Egypt

Endourology & Stones

10:52 - 11:03 CET

The Positive Urine Culture Dilemma: In Search of an Evidence-based Strategy in Endourology

Endourology & Stones

11:03 - 11:14 CET

Practical Challenges of Flexible and Navigable Suction UAS? How I Rescue Myself

Speaker:

Endourology & Stones

11:14 - 11:25 CET

Hemostatic Properties of Magneto in Enucleation Saves the Day

Speaker:

Endourology & Stones

11:25 - 11:36 CET

Bleeding in Large Volume Stone Surgery in RIRS

Endourology & Stones

11:36 - 11:47 CET

Ten Evidence Based Commandments to Prevent Iatrogenic Injuries in FURS

Speaker: – India

Endourology & Stones

11:47 - 12:00 CET

Discussion/Q&A

Endourology & Stones

10:30 CET

CHALLENGING CASES IN URETHRAL RECONSTRUCTION

10:30 - 10:37 CET

Management of Reconstruction in Spinal Cord Injury

Speaker: – Hospital del Trabajador

10:37 - 10:44 CET

Using Penile Flaps in CA Urethra

10:44 - 10:51 CET

Radiation Induced Urethral strictures

10:51 - 10:58 CET

Rectourethral Fistula

10:58 - 11:05 CET

Stricture after BPH Surgery

Speaker: – UROKUL

11:05 - 11:12 CET

Stricture after Prostate Cancer

11:12 - 11:19 CET

Perineal Urethrostomy

Speaker: – UROKUL

11:19 - 11:26 CET

Sexually Transmitted Diseases Induced Strictures

11:26 CET

ADVANCES IN URETHRAL RECONSTRUCTION

11:26 - 11:33 CET

Optilume-Udpated Results and Current Indication's

Speaker: – University of Queensland

11:33 - 11:40 CET

Non Transecting Techniques in Urethra and Ureter

Speaker: – UROKUL

11:40 CET

FUTURE

11:40 - 11:45 CET

Future of Urethral Reconstruction

Speaker: – University of Queensland

11:45 - 11:50 CET

Future of Urethral Reconstruction

Speaker: – Hospital del Trabajador

11:50 - 12:00 CET

Q&A

10:30 - 12:00 CET

Instructional Course: Challenges, Advances and Future in Urethral Reconstruction

Co-Chair: – Hospital del Trabajador

Reconstruction

10:30 - 12:00 CET

Master Class: BPH/LUTS in 2026: A Practical, Resource-tiered Clinical Algorithm (Clinic to OR)

Co-Chair: – India

Co-Chair: – Niguarda Hospital

BPH/LUTS

10:30 - 10:40 CET

Diagnostic Workup & LUTS Phenotyping That Scales Globally

BPH/LUTS

10:40 - 10:52 CET

Medical Therapy Sequencing & LUTS/OAB Overlap: Practical Combination Strategies

Speaker: – Sapienza University of Rome

BPH/LUTS

10:52 - 11:04 CET

Who Progresses? When to Move from Meds to Intervention

Speaker:

BPH/LUTS

11:04 - 11:18 CET

Choosing the Right Procedure: Size, Anatomy (median Lobe), Bleeding Risk, and Patient Prioritie

Speaker: – University of Foggia

BPH/LUTS

11:18 - 11:38 CET

MIST in Real-world Practice: Patient Selection, Counseling, and Outcomes

Speaker: – Hong Kong

BPH/LUTS

11:38 - 12:00 CET

Discussion / Q&A

Moderator: – India

Moderator: – Niguarda Hospital

BPH/LUTS

10:30 - 12:00 CET

Master Class: Global Andrology in 2026 - Delivering Sexual & Reproductive Care Across Resource Settings

Co-Chair:

Andrology/Sexual Medicine

10:30 - 10:42 CET

The Global Burden of Male Sexual Dysfunction: Why Andrology Matters to Public Health

Andrology/Sexual Medicine

10:42 - 10:54 CET

Erectile Dysfunction as a Cardiometabolic Disease: Global Implications

Andrology/Sexual Medicine

10:54 - 11:06 CET

Low Testosterone: Treat, Don’t Treat, or Overtreat?

Andrology/Sexual Medicine

11:06 - 11:18 CET

Male Infertility in Resource-limited Settings

Andrology/Sexual Medicine

11:18 - 11:30 CET

Fertility, Masculinity & Health-seeking Behavior: The Hidden Barrier to Global Andrology

Speaker:

Andrology/Sexual Medicine

11:30 - 12:00 CET

Panel Discussion & Q&A

Andrology/Sexual Medicine

10:30 - 12:00 CET

Master Class: Testicular Cancer 2026 - Precision, Pragmatism, and the Long Game

Co-Chair: – University of California San Diego

Co-Chair: – Hassan II University Hospital

Testis Cancer

10:30 - 10:38 CET

Guideline-directed Care of Patients with Gcts: What’s New?

Testis Cancer

10:38 - 10:46 CET

Stage I Seminoma and NSGCT: How Little Is Enough? – Christian Fankhauser (Switzerland) – 8 mins 1. key focus: 1. surveillance vs Adjuvant therapy 2. psychosocial and Fertility outcomes 3. shared Decision-making Frameworks

Testis Cancer

10:46 - 10:54 CET

Biomarkers that matter: miRNA-371 and ctDNA ?

Speaker:

Testis Cancer

10:54 - 11:02 CET

Stage II Seminoma: Modern Algorithms

Speaker: – University of California San Diego

Testis Cancer

11:02 - 11:10 CET

Primary RPLND for Marker-positive NSGCT: Ready for Prime Time?

Testis Cancer

11:10 - 11:18 CET

Robotic RPLND: Progress and Pitfalls

Speaker:

Testis Cancer

11:18 - 11:26 CET

Survivorship Is the Endpoint: Long-term Toxicity, Fertility, and Quality of Life

Speaker: – Hassan II University Hospital

Testis Cancer

11:26 - 11:34 CET

Optimal Approach to Post-chemotherapy RPLND

Speaker: – University Hospital Cologne

Testis Cancer

11:34 - 12:00 CET

Case-based management of GCTs

Moderator: – Tata Memorial Hospital, Homi Bhabha National Institute

Panelist: – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel

Panelist:

Testis Cancer

12:00 - 12:45 CET

8th Bench-to-bedside Uro-oncology: GU Cancers Triad Meeting - LUNCHEON SYMPOSIUM

12:00 - 12:45 CET

HER2-Targeted Antibody-Drug Conjugates in Metastatic Bladder Cancer: A New Era of Precision Oncology

12:00 - 13:15 CET

Networking Break

12:50 - 14:30 CET

8th Bench-to-bedside Uro-oncology: GU Cancers Triad Meeting - KIDNEY CANCER

Moderator: – McGill University

12:50 - 13:05 CET

KIM-1 as a Prognostic Biomarker in RCC

Speaker:

13:05 - 13:13 CET

Open

Speaker: – Moffitt Cancer Center

13:05 - 13:30 CET

Debate: Open vs Robotic Surgery in IVC Thrombus

Moderator: – McGill University

13:13 - 13:21 CET

Robotic

Speaker: – CHU Bordeaux - I.CaRe Bordeaux

13:30 - 13:45 CET

Adjuvant Treatment for Localized RCC

13:45 - 14:15 CET

Case-Based Discussion: What Is the Best Approach for Robotic Partial Nephrectomy?

Moderator: – McGill University

13:45 - 14:15 CET

Retro

13:45 - 14:15 CET

Trans

14:15 - 14:30 CET

Metastatic RCC - Second-Line Treatment and Beyond

13:15 - 14:00 CET

Hot Topic: Navigating the Unexpected: A Reality Check - What We Learn Only When We Fail

Co-Chair: – Medicity Guwahati

Co-Chair:

Co-Chair: – Sefako Makgatho Health Sciences University

Complications/Failures

13:15 CET

Part A: Endourology Complication Management

Moderator: – Sefako Makgatho Health Sciences University

Moderator:

Moderator: – Sengkang General Hospital

Complications/Failures

13:15 - 13:22 CET

Ureteric Stricture: Single or Tandem Stent?

Speaker:

Complications/Failures

13:22 - 13:29 CET

Real Nightmares in PCNL

Complications/Failures

13:29 - 13:36 CET

Rendezvous Procedure: Outcomes and Limitations

Complications/Failures

13:36 - 13:43 CET

MIST: Management of Failure and Complications

Speaker: – Italy

Complications/Failures

13:43 - 13:50 CET

Laser Prostatic Enucleations: What Can Possibly Go Wrong and How to Prevent It

Complications/Failures

13:50 - 14:00 CET

Q&A

Complications/Failures

14:00 CET

Part B: The Surgical Challenges

Moderator: – Medicity Guwahati

Moderator:

Complications/Failures

14:00 - 14:07 CET

Positive Surgical Margins in PN – Failure or Selection Issue

Complications/Failures

14:07 - 14:14 CET

Simple Robotic Prostatectomy? Complications, Their Management and Prevention

Complications/Failures

14:14 - 14:21 CET

Concept of Preventable vs Acceptable Complications

Speaker: – North Bristol NHS Trust

Complications/Failures

14:21 - 14:28 CET

Extra Anatomic Stents When Treating Complex Ureteric Strictures

Complications/Failures

14:28 - 14:35 CET

Rectal Injury During Lap Radical Prostatectomy – Prevention and Salvage Options

Complications/Failures

14:35 - 14:40 CET

The “5R Model”

Speaker: – Medicity Guwahati

Complications/Failures

14:40 - 14:45 CET

Q&A

Complications/Failures

13:15 - 14:45 CET

Instructional Course: Anatomy-Driven Endoscopic Enucleation for BPH: Energy Selection, Plane Control, Complication Avoidance and Surgical Alternatives

Chair: – University of Foggia

BPO/LUTS

13:15 CET

Overview of AEEP: Patient Selection, “Anatomy-First” Principles, and Outcomes

BPO/LUTS

13:15 - 13:20 CET

Advantages

BPO/LUTS

13:20 - 13:25 CET

Disadvantages

Speaker: – Niguarda Hospital

BPO/LUTS

13:25 CET

Critical Surgical Points and Alternative Surgical Strategies

BPO/LUTS

13:25 - 13:30 CET

En-Bloc Vs 2-Lobe Vs 3-Lobe Enucleation: How to Choose

Speaker: – University of Foggia

BPO/LUTS

13:30 - 13:35 CET

Apical Mucosal-Sparing and Early Apical Release: Continence-Focused Tips

Speaker: – The Chinese University of Hong Kong

BPO/LUTS

13:35 - 13:40 CET

Scope Size and Irrigation Strategy: Visibility, Urethral Safety and Efficiency

Speaker: – University of Foggia

BPO/LUTS

13:40 - 13:50 CET

When AEEP Is Not the Answer: Alternative Strategies And “Exit Plans”

Speaker: – Niguarda Hospital

BPO/LUTS

13:50 - 13:55 CET

Discussion

BPO/LUTS

13:55 CET

Different Energy Sources and Procedures (Video Highlighting The Differences)

BPO/LUTS

13:55 - 14:05 CET

BipoLEP/PlasmaLEP

Speaker: – The Chinese University of Hong Kong

BPO/LUTS

14:05 - 14:15 CET

HoLEP and MoLEP

Speaker: – University of Foggia

BPO/LUTS

14:15 - 14:25 CET

ThuLEP vs ThufLEP

Speaker: – The Chinese University of Hong Kong

BPO/LUTS

14:25 - 14:35 CET

Surgical Alternatives: Aquablation, Simple Prostatectomy, Etc. - Where They Fit In 2026

BPO/LUTS

14:35 - 14:45 CET

Discussion

BPO/LUTS

14:45 CET

Closing Remarks

Speaker: – Niguarda Hospital

BPO/LUTS

13:15 - 14:45 CET

Interactive Session: Complex Pelvic Floor Disorders - Functional and Neurologic Considerations

Female Pelvic Medicine

13:15 CET

Global Roundtable: Underactive Bladder: Has Our Understanding of Underactive Bladder Improved over the past Decade?

Female Pelvic Medicine

13:15 - 13:21 CET

Diagnosis

Female Pelvic Medicine

13:21 - 13:27 CET

Pharmacotherapy

Female Pelvic Medicine

13:27 - 13:33 CET

Non-pharmacologic Options Including ESWL and Stem Cell Therapy

Female Pelvic Medicine

13:33 - 13:39 CET

Intravesical Electrical Stimulation and Neuromodulation

Speaker: – Tabriz University of Medical Sciences, Tabriz, Iran.

Female Pelvic Medicine

13:45 CET

Considerations for the Female Neurourological Patient

Female Pelvic Medicine

13:45 - 13:55 CET

UTI Prevention and Management in the Pregnant Female Neurourological Patient

Female Pelvic Medicine

13:55 - 14:05 CET

Peripartum Considerations for the Pregnant Reconstructed Neurourological Patient

Female Pelvic Medicine

14:15 CET

Global Roundtable: Challenging POP Cases

Female Pelvic Medicine

14:15 - 14:23 CET

Management of POP After Radical Genitourinary Surgery or Pelvic XRT

Female Pelvic Medicine

14:23 - 14:31 CET

Surgical Management of POP in Patients with Lower Urinary Tract Stones

Female Pelvic Medicine

14:31 - 14:39 CET

Management of POP in Females with Spina Bifida

Speaker: – Baylor College of Medicine

Female Pelvic Medicine

13:15 - 14:45 CET

Interactive Session: Technology & Sustainability in Endourology Interventions

Co-Chair: – Botkin Moscow Multidisciplinary Clinical Medical Center

Co-Chair: – Menoufia University

Co-Chair: – Seoul National University

Endourology & Stones

13:15 - 13:26 CET

Smart Lithotripsy with Thulium Fiber Laser: Real-time Stone and Tissue Recognition

Speaker:

Endourology & Stones

13:26 - 13:37 CET

My Best Laser for Enucleation

Speaker: – Veterans Memorial Medical Center Philippines

Endourology & Stones

13:37 - 13:48 CET

Robotic Ureteroscopy: What I Have , What I Need

Speaker: – Seoul National University

Endourology & Stones

13:48 - 13:59 CET

Office‑based Stone Therapy: Where Do We Stand

Endourology & Stones

13:59 - 14:10 CET

Go Small or Go Home : Are Small Scopes the Future ?

Speaker: – "Saint John" Emergency Clinical Hospital

Endourology & Stones

14:10 - 14:21 CET

Next-generation Stents to Improve Outcomes

Endourology & Stones

14:21 - 14:32 CET

Are We Ready to Digitalise Everything in Endourology

Speaker: – Fortune Urology Clinic

Endourology & Stones

14:32 - 14:45 CET

Discussion/Q&A

Endourology & Stones

13:15 - 14:45 CET

International Society of Reconstructive Urology (ISORU) Symposium

13:15 - 14:45 CET

SIU Innovators

14:30 - 16:30 CET

Workshop: Laparascopy for Beginners

Co-Chair: – Newcastle's Freeman Hospital

Co-Chair: – Hospital Alemán of Buenos Aires

14:35 - 16:15 CET

8th Bench-to-bedside Uro-oncology: GU Cancers Triad Meeting - PROSTATE CANCER

Moderator: – Niguarda Hospital

14:35 - 14:50 CET

Risk-Adapted Prostate Cancer Screening

Speaker: – Medical Faculty, Heinrich-Heine University Düsseldorf

14:50 - 14:58 CET

Pros

14:50 - 15:15 CET

Debate: Micro-Ultrasound Can Replace MRI-Guided Prostate Biopsy

Moderator: – Niguarda Hospital

14:58 - 15:06 CET

Cons

Speaker: – University of Palermo

15:15 - 15:30 CET

Innovative Use of PSMA-Radioguided Surgery to Identify a Novel Immune Therapeutic Strategy for Prostate Cancer

Speaker:

15:30 - 15:45 CET

Role of Radiotherapy in Prostate Cancer Management

15:45 - 16:15 CET

Case-Based Discussion: Treatment Decision-Making in Metastatic Castrate-Sensitive Prostate Cancer - A Multidisciplinary Tumour Board

Moderator:

Panelist: – Medical Faculty, Heinrich-Heine University Düsseldorf

Panelist: – University of Palermo

14:45 - 15:15 CET

Networking Break

15:15 - 16:45 CET

Hot Topic: From Urethra to Groin - High-Stakes Decisions in Rare GU Cancers

Chair: – Moffitt Cancer Center

Penile/Urethra Cancer

15:15 - 15:18 CET

Welcome

15:18 - 15:31 CET

Primary Urethral Carcinoma in 2026: Staging and Multimodality Pathways

Speaker: – Moffitt Cancer Center

Penile/Urethra Cancer

15:31 CET

Debate: “This House would perform pelvic lymph node dissection (rather than adjuvant pelvic radiotherapy/chemoradiotherapy or observation) for non-suspicious pelvic nodes but high-risk node-positive penile cancer after ILND.”

Moderator: – University of Sydney

Penile/Urethra Cancer

15:31 - 15:41 CET

For

Speaker: – St George's University Hospitals

Penile/Urethra Cancer

15:41 - 15:51 CET

Against

Speaker:

Penile/Urethra Cancer

15:51 - 15:56 CET

Q&A

Penile/Urethra Cancer

15:56 - 16:11 CET

New Developments in Systemic Therapy & Biomarkers in Penile Cancer: What’s Actionable Now and Who Should Go to Trials

Penile/Urethra Cancer

16:11 - 16:41 CET

Penile Cancer Interactive Case Clinic

Moderator: – Tata Memorial Hospital, Homi Bhabha National Institute

Penile/Urethra Cancer

16:41 - 16:45 CET

Wrap-Up/Q&A

Penile/Urethra Cancer

15:15 - 16:45 CET

Instructional Course: Advanced Management of Urinary Tract Infections

Infections and Inflammation

15:15 - 16:45 CET

Metastatic RCC - Second-Line Treatment and Beyond

15:15 - 16:45 CET

Instructional Course: Advanced Ureteroscopy: Solving Complex Problems

Chair: – New York Medical College